-
3741
-
3742
Psychological Distress among Pharmacists during Second Wave of Pandemic: A Cross-Sectional Study
Published 2022-01-01“…A cross-sectional analytical design was adopted to study the psychological distress of pharmacists working in community pharmacies in Bharatpur. Materials and Methods. Purposive sampling method was used to select 172 community pharmacists. …”
Get full text
Article -
3743
The Perspective of Therapeutic Antibody Marketing in Iran: Trend and Estimation by 2025
Published 2021-01-01Get full text
Article -
3744
-
3745
-
3746
CRT-D Therapy in Patients with Decompensated NYHA Class-Four CHF
Published 2012-01-01Get full text
Article -
3747
-
3748
-
3749
Effect of 3-hydrazinylquinoxaline-2-thiol hydrogel on skin wound healing process in diabetic rats
Published 2024-08-01Get full text
Article -
3750
Patenting of an Invention and an Utility Model Whose Object Is an Innovative Medicinal Product
Published 2021-07-01“…Gaps and inconsistencies have been identified in the legislation that regulates intellectual property rights protection in the field of pharmacy. In particular, contradictions in the legal regulation of the examination of applications for a patent for an invention or utility model, the objects of which are innovative medicinal products. …”
Get full text
Article -
3751
The synthesis and research of the naphthalimide G-quadruplex probe targeting hybrid G4s
Published 2025-01-01Get full text
Article -
3752
Research progress of breast cancer surgery during 2010–2024: a bibliometric analysis
Published 2024-12-01Get full text
Article -
3753
-
3754
Usual prevention in unusual settings: A scoping review of place-based health interventions in public-facing businesses.
Published 2025-01-01“…The most common unconventional public-facing business settings for health interventions included barbershops or beauty salons; interventions included health education, preventative screenings, pharmacy services, and connections to local healthcare providers and resources. …”
Get full text
Article -
3755
Protocol for measuring the auxin-induced changes of m6A modification
Published 2025-03-01Get full text
Article -
3756
Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazi...
Published 2018-01-01“…During the 6-month post-index period after HD diagnosis, HD patients incurred higher all-cause healthcare costs ($20 204) vs the 6-month pre-index period ($6057), driven by higher hospitalization and pharmacy costs. **Conclusions:** A small percentage of HD patients with chorea were treated with tetrabenazine and discontinuation rates were high among those receiving treatment, with a median time to discontinuation of 9 months.…”
Get full text
Article -
3757
A ketogenic diet regulates microglial activation to treat drug addiction
Published 2025-01-01Get full text
Article -
3758
-
3759
Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations
Published 2025-01-01Get full text
Article -
3760
Analyzing disease control through testing game approach embedded with treatment and vaccination strategies
Published 2025-02-01Get full text
Article